Wave Life Sciences Ltd. Reports Q2 2026 Financial Results

What Happened
Wave Life Sciences Ltd. announced its financial results for the quarter ended June 30, 2026 in a press release dated July 30, 2026. The company furnished that press release as Exhibit 99.1 to the Form 8-K and also updated its corporate/investor presentation, furnished as Exhibit 99.2 and posted on the company’s Investors page (http://ir.wavelifesciences.com/). The disclosures were furnished (not filed) under Items 2.02 and 7.01 of the Form 8-K.

Key Details

• Announcement date: July 30, 2026; quarter reported: quarter ended June 30, 2026 (Q2 2026).
• Press release with the financial results: furnished as Exhibit 99.1 to the 8-K.
• Updated corporate presentation: furnished as Exhibit 99.2 and available on the company’s investor website.
• The items were furnished (not “filed”), meaning the materials are provided to investors but are not subject to Section 18 liability or automatically incorporated by reference into other SEC filings.

Why It Matters
For investors, this 8-K signals Wave’s latest quarterly earnings and any accompanying metrics or guidance will be contained in the furnished press release and updated slides. Review the press release and presentation on the company’s Investor Relations page to see the reported revenue, earnings, cash position, operational updates, or guidance that could affect valuation or near-term expectations.